Possible therapeutic agents for COVID-19: a comprehensive review
KM Elhusseiny, FAE Abd-Elhay… - Expert Review of Anti …, 2020 - Taylor & Francis
Introduction Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) has emerged
in China. There are no available vaccines or antiviral drugs for COVID-19 patients. Herein …
in China. There are no available vaccines or antiviral drugs for COVID-19 patients. Herein …
[HTML][HTML] An overview of the safety, clinical application and antiviral research of the COVID-19 therapeutics
D Wang, Z Li, Y Liu - Journal of infection and public health, 2020 - Elsevier
Since a novel coronavirus pneumonia outbreak in late December 2019, coronavirus disease-
19 (COVID-19) epidemic has gradually spread worldwide, becoming a major public health …
19 (COVID-19) epidemic has gradually spread worldwide, becoming a major public health …
[HTML][HTML] Effective drugs used to combat SARS-CoV-2 infection and the current status of vaccines
A Awadasseid, Y Wu, Y Tanaka, W Zhang - Biomedicine & …, 2021 - Elsevier
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a causal factor of the
coronavirus disease 2019 (COVID-19). Drug repurposing, portraying patented drugs as a …
coronavirus disease 2019 (COVID-19). Drug repurposing, portraying patented drugs as a …
[HTML][HTML] Recent advances in management of COVID-19: A review
Abstract The coronavirus disease 2019 (COVID-19) pandemic caused and is still causing
significant mortality and economic consequences all over the globe. As of today, there are …
significant mortality and economic consequences all over the globe. As of today, there are …
Current targeted therapeutics against COVID-19: based on first-line experience in China
Y Zhang, Q Xu, Z Sun, L Zhou - Pharmacological research, 2020 - Elsevier
SARS-CoV-2 is a novel strain, causing a global pandemic since the end of 2019. The
majority of patients showed nonspecific symptoms such as fever, dry cough, and fatigue …
majority of patients showed nonspecific symptoms such as fever, dry cough, and fatigue …
Advances in the possible treatment of COVID-19: A review.
P Chibber, SA Haq, I Ahmed, NI Andrabi… - European journal of …, 2020 - Elsevier
The emergence of the global pandemic caused by novel severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) has put a challenge to identify or derive the therapeutics for its …
coronavirus 2 (SARS-CoV-2) has put a challenge to identify or derive the therapeutics for its …
[PDF][PDF] Advances in SARS-CoV-2: a systematic review.
YX Bai, YH Xu, X Wang, C Sun, Y Guo… - European Review for …, 2020 - europeanreview.org
OBJECTIVE: In December 2019, Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-
CoV-2) infection broke out in Wuhan, China. However, we still lack a comprehensive …
CoV-2) infection broke out in Wuhan, China. However, we still lack a comprehensive …
COVID-19 treatment: close to a cure? A rapid review of pharmacotherapies for the novel coronavirus (SARS-CoV-2)
Y Song, M Zhang, L Yin, K Wang, Y Zhou… - International journal of …, 2020 - Elsevier
Currently, there is no approved therapy for coronavirus disease 2019 (COVID-19). The
World Health Organization (WHO) therefore endorses supportive care only. However …
World Health Organization (WHO) therefore endorses supportive care only. However …
[HTML][HTML] COVID-19 antiviral and treatment candidates: current status
E Españo, D Kim, J Kim, SK Park, JK Kim - Immune network, 2021 - ncbi.nlm.nih.gov
Abstract The coronavirus disease 2019 (COVID-19) pandemic caused by the severe acute
respiratory syndrome coronavirus 2 has severely impacted global health and economy …
respiratory syndrome coronavirus 2 has severely impacted global health and economy …
[HTML][HTML] Potential treatment options for COVID-19: a comprehensive review of global pharmacological development efforts
Abstract Coronavirus disease-2019 (COVID-19), first reported in China during December of
2019, is caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) …
2019, is caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) …